← Back to Search

Behavioural Intervention

Texting Platform for Recurrent UTIs (Urotrust Trial)

N/A

Recruiting

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18 years or older

Females who currently meet the criteria for recurrent UTIs

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

Urotrust Trial Summary

This trial will test if a text-based platform can help people better manage recurrent UTIs and improve their sense of self-efficacy.

Who is the study for?

This trial is for women over 18 with recurrent UTIs who can give informed consent, follow the study procedures, and have a mobile device that can text. They must be able to read/write English but cannot join if they have urinary system anomalies, certain bladder conditions, recent pregnancy, uncontrolled diabetes or are on specific medications.Check my eligibility

What is being tested?

Researchers are testing whether an EHR-integrated texting platform offering guidance and education on managing recurrent UTIs improves patients' confidence in handling their condition compared to usual care. The effectiveness will be measured by changes in self-efficacy scores after using the platform.See study design

What are the potential side effects?

Since this intervention involves a texting platform for educational purposes rather than medication or invasive treatment, there are no direct medical side effects expected from participating in this clinical trial.

Urotrust Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I frequently get urinary tract infections.

Urotrust Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Rate of unnecessary antibiotics

Secondary outcome measures

Antibiotic prescriptions

Healthcare utilization

Healthcare-related quality of life: EQ-5D-5L score

+4 more

Urotrust Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Electronic health record (EHR)-integrated texting platformExperimental Treatment1 Intervention

Patients will be enrolled into a texting platform for the management of recurrent UTI.

Group II: Usual careActive Control1 Intervention

Patients will receive usual care through their providers.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Independence Blue CrossOTHER

6 Previous Clinical Trials

126,437 Total Patients Enrolled

University of PennsylvaniaLead Sponsor

2,006 Previous Clinical Trials

42,882,952 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the current research seeking participants aged 25 and over?

"Per the medical study's prerequisites, potential participants must be 18-100 years old."

Answered by AI

Are participants being enrolled in this trial at present?

"Indeed, clinicaltrials.gov indicates that the medical study is currently gathering participants. This trial was initially announced on October 16th 2023 and has since been updated twice; lastly on the 25th of October 2023. At present, 60 patients are needed to be recruited from one site for this research."

Answered by AI

What type of individuals are ideal candidates for this medical experiment?

"This medical trial calls for 60 individuals, aged 18 to 100, with urinary tract infections. Requirements include a signed informed consent form from each participant and the ability to communicate via text message in English. Additionally, only female participants who meet recurrent UTI criteria can be enrolled into this study."

Answered by AI

How many participants are currently enrolled in this research?

"Affirmative, the information hosted on clinicaltrials.gov suggests that this experiment is currently recruiting test subjects. It was initially posted on October 16th 2023 and most recently updated on October 25th 2023 with the goal of enrolling 60 participants from a single clinic."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

EHR-integrated rUTI Texting Platform

Lily Arya 2024. "EHR-integrated rUTI Texting Platform". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06035601.